ArticleFrontiers in pharmacology2025

Population pharmacokinetic analysis of rivaroxaban in healthy volunteers and patients with radiofrequency ablation of non-valvular atrial fibrillation in China.

Fangfang Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.